A regulatory focused update, published 2026 02 11, reports on a completed trial comparing two miniscrew bone borne expanders to a conventional Hyrax in adolescents. The record outlines three intervention arms and a tooth borne comparator within an orthodontic appliance context and notes the sponsor as University of Roma La Sapienza. While the entry confirms completion, it does not provide published results in the supplied text.
The trial adds a direct head to head comparison between a bone anchored approach and a traditional tooth anchored expander. The sponsor is University of Roma La Sapienza and the study is listed on ClinicalTrials.gov as NCT07404488. The three interventions involve a miniscrew supported expander with two screws, a four screws supported rapid maxillary expansion approach, and a conventional Hyrax expander used as a comparator. The record identifies the condition as Orthodontic Appliance and notes the study status as Completed. No trial results are provided in the supplied text, so conclusions about performance await publication and regulatory review.
What changed in adolescent maxillary expansion device trials?
The trial adds a direct comparison between a miniscrew anchored expander and a conventional tooth anchored expander. It addresses device anchorage as a factor that may influence expansion mechanics patient tolerance and potential long term effects. The sponsor and registry information help regulators track intended use and safety expectations for future data submissions. The absence of published results within the source means regulators and clinicians should await peer reviewed findings before applying any conclusions to clinical practice.
What is the study design and who is eligible?
The entry describes an orthodontic appliance focus and three intervention configurations. The comparator is a Hyrax expander. The record does not specify randomization details or sample size in the provided text. The adolescents targeted by this trial align with typical age ranges for maxillary expansion investigations. The trial will require regulatory review of safety and performance once results are available.
What are regulatory implications for safety and performance?
Miniscrew anchored expanders represent devices that rely on bone anchorage. The record signals an intent to compare safety and performance indicators against a conventional tooth anchored device. Regulators will look for outcomes related to skeletal changes dental tipping patient tolerance and complication rates. Until results are published the record serves as a protocol reference for anticipated indications and performance benchmarks in adolescents.
Who is behind this trial and what disclosures exist?
University of Roma La Sapienza is listed as the sponsor. The available record does not reveal additional funding sources or conflicts of interest in the provided text. Regulators will seek full disclosures during any future data submissions or product clearance activities.
What happens next for clinicians and regulators?
With the trial status shown as completed and no results in the text, stakeholders should monitor official postings on ClinicalTrials.gov and the sponsor communications for data on performance differences and safety outcomes. When results become available clinicians can assess whether a bone anchored approach offers advantages over tooth anchored expansion in adolescents and regulators can evaluate whether device labeling and intended use align with evidence.
FAQ
- Q1 What devices are compared in this trial? The trial compares two miniscrew bone anchored expanders two screws and four screws with a conventional Hyrax.
- Q2 Who is the sponsor? The sponsor listed is University of Roma La Sapienza.
- Q3 What is the trial status? The provided record shows the study as Completed.
Conclusion
In summary this record signals a regulatory aligned comparison of bone anchored and tooth anchored maxillary expansion devices in adolescents. No results are posted in the source, further data will determine if bone anchorage changes safety performance or patient experience. Regulators and clinicians should await published findings before adapting practice or clearance decisions.
Disclaimer
This article is intended for professionals and is not legal advice. It reflects information from the source text and public registry data only. It does not replace regulatory guidance or case specific counsel.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07404488?term=medical+device